AEON Biopharma, Inc. - Class A Common Stock (AEON)

CUSIP: 00791X100

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Class A Common Stock
Shares outstanding
39,736,842
Total 13F shares
8,666,712
Share change
+3,915,330
Total reported value
$56,800,421
Price per share
$7.20
Number of holders
20
Value change
+$26,503,906
Number of buys
11
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 00791X100?
CUSIP 00791X100 identifies AEON - AEON Biopharma, Inc. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) as of Q4 2023

As of 31 Dec 2023, AEON Biopharma, Inc. - Class A Common Stock (AEON) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,666,712 shares. The largest 10 holders included Polar Asset Management Partners Inc., Atalaya Capital Management LP, Ikarian Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Formidable Asset Management, LLC, BOOTHBAY FUND MANAGEMENT, LLC, NORTHERN TRUST CORP, and BANK OF AMERICA CORP /DE/. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.